Eric Van Den Hove
About Eric Van Den Hove
Eric Van Den Hove is an R and D System Engineer specializing in Beam Production Systems at Iba, where he has worked since 2015. He holds a Master's degree in Mechanical Engineering and has experience in cyclotron engineering and interdisciplinary collaboration.
Work at IBA
Eric Van Den Hove has been employed at IBA since 2015, serving as an R and D System Engineer for the Beam Production System. In this role, he contributes to the design and development of advanced systems, specifically the Proteus One cyclotron, which is utilized in proton therapy. Prior to his current position, he worked as a Cyclotron Field Engineer at IBA from 2012 to 2015. His experience at IBA spans nearly a decade, during which he has engaged in various projects that require collaboration across multiple disciplines.
Education and Expertise
Eric Van Den Hove holds a Master of Engineering degree in Mechanical Engineering from Université Catholique De Louvain, where he studied from 2006 to 2011. He also attended Universitat Politècnica De València for one year in 2010 to 2011, further enhancing his engineering knowledge. Since 2015, he has been studying at the Joint Universities Accelerator School at CERN, focusing on particle accelerator technologies. His educational background equips him with a strong foundation in engineering principles and advanced technical skills.
Background
Eric Van Den Hove began his professional career at IBA, where he initially worked as a Cyclotron Field Engineer for three years before transitioning to his current role as an R and D System Engineer. His work involves collaboration with physicists, technical drawers, technology experts, and manufacturing and field engineers. This multidisciplinary approach allows him to address complex challenges in the development of particle accelerator technologies.
Achievements
Eric Van Den Hove has made significant contributions to the design and development of the Proteus One cyclotron, a compact proton therapy system. His role involves tackling practical and reasoning challenges associated with the advanced technologies used in the particle accelerators domain. His work at IBA reflects a commitment to advancing medical technology through engineering innovation.